Brendan Kelly

Founder at

A2a Pharmaceuticals, Inc.

Finance

Consumer Services

Technology Services

Profile

Brendan is a Vice President at Lightstone Ventures evaluating opportunities in the biopharmaceutical sector.
Brendan has a background in medicinal chemistry and computational drug discovery research, and life sciences strategy.
Prior to Lightstone, Brendan was Director of New Product Planning at Q32 Bio, where he helped to define value propositions and commercial strategy for the company’s lead assets and discovery platform.
Brendan was previously a life sciences strategy consultant at L.E.K.
Consulting, working on projects across therapeutic areas, modalities and technologies, including pipeline optimization, go-to-market strategies, BD and M&A due diligence.
Brendan’s research at Stanford Computer Science, University of Toronto and Trinity College Dublin focused on computational methods of small molecule drug discovery for oncology and neuroscience targets.
With his background in research and strategy, Brendan is keenly Interested in the intersection of innovative science, company formation and strategy, particularly in the pursuit of new therapeutics for patients in need.

Brendan Kelly active positions

Companies	Position	Start
A2a Pharmaceuticals, Inc. A2a Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops proprietary computational systems and new therapeutics that serve highly unmet patient needs	Founder	-
LSV CAPITAL MANAGEMENT LLC LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements.	Private Equity Investor	2021-10-31

All active positions of Brendan Kelly

Former positions of Brendan Kelly

Companies	Position	End
Q32 Bio, Inc. Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform	Corporate Officer/Principal	2021-10-31
OS Fund LLC OS Fund LLC Investment ManagersFinance OS Fund invests in companies located in the United States. The firm targets companies operating in the fields of genomics, synthetic biology, computationally derived therapeutics, advanced materials and diagnostics. It provides financing for early stage capital requirements.	Consultant / Advisor	2021-10-31

See the detail of Brendan Kelly's experience

Training of Brendan Kelly

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brendan Kelly's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Trinity College Dublin Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
LSV CAPITAL MANAGEMENT LLC LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements.	Finance
OS Fund LLC OS Fund LLC Investment ManagersFinance OS Fund invests in companies located in the United States. The firm targets companies operating in the fields of genomics, synthetic biology, computationally derived therapeutics, advanced materials and diagnostics. It provides financing for early stage capital requirements.	Finance
A2a Pharmaceuticals, Inc. A2a Pharmaceuticals, Inc. Packaged SoftwareTechnology Services Develops proprietary computational systems and new therapeutics that serve highly unmet patient needs	Technology Services
Q32 Bio, Inc. Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform	Health Technology